Esomeprazole Magnesium Capsule, Delayed Release
Product Images NDC 72789-352

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Esomeprazole Magnesium (NDC 72789-352). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

72789352 Label (72789352)

Label for Esomeprazole Magnesium 20 mg delayed-release capsules USP by PD-Rx Pharmaceuticals, Inc. The label indicates 30 capsules per container, Rx only, with storage instructions and manufacturer information. It includes the NDC 72789-352-30 and a barcode.*

FDA Label Image

Figure 2: Maintenance Of Healing Rates Of Ee In Adults By Month (study 177) (Esomeprazole Fig1)

A line graph displaying the percent maintained over six months for different doses of Esomeprazole Magnesium and a placebo. The graph includes data for 40 mg, 20 mg, and 10 mg doses of Esomeprazole Magnesium, compared to placebo, with scheduled visit markers on the timeline.*

FDA Label Image

Figure 3: Maintenance Of Ee Healing Rates In Adults By Month (study 178) (Esomeprazole Fig2)

A line chart showing the percentage maintained over a 6-month period for patients receiving Esomeprazole Magnesium at doses of 40 mg, 20 mg, 10 mg, and placebo. The y-axis represents percent maintained, and the x-axis shows months with scheduled visits marked. Higher doses of Esomeprazole Magnesium show greater maintenance compared to placebo and lower doses.*

FDA Label Image

Figure 4: Percent Of Patients Symptom-free Of Heartburn By Day (study 225) (Esomeprazole Fig3)

A line graph comparing the percent of patients symptom-free over 28 diary days for Esomeprazole Magnesium delayed-release capsules at 40 mg, 20 mg, and a placebo. The x-axis represents diary days from 0 to 28, and the y-axis shows the percent of patients symptom-free from 0% to 100%. Both Esomeprazole groups show a higher and increasing percentage of symptom-free patients over time compared to placebo.*

FDA Label Image

Figure 5: Percent Of Patients Symptom-free Of Heartburn By Day (study 226) (Esomeprazole Fig4)

A line graph showing the percent of patients symptom-free over 28 diary days for Esomeprazole Magnesium delayed-release capsules at 40 mg and 20 mg doses, compared to placebo. The y-axis represents the percentage of symptom-free patients, and the x-axis represents diary days from 0 to 28. Three lines track the symptom-free percentages for the 40 mg, 20 mg doses, and placebo over the study period.*

FDA Label Image

Chemical Structure (Esomeprazole Str)

Chemical structure of esomeprazole magnesium, showing the molecular arrangement including sulfur, nitrogen, oxygen atoms, aromatic rings, methyl and methoxy groups, magnesium ions, and hydration waters (2H2O).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.